Christopher F. O'Brien
2016
In 2016, Christopher F. O'Brien earned a total compensation of $3.5M as Chief Medical Officer at Neurocrine Biosciences, a 29% increase compared to previous year.
Compensation breakdown
| Bonus | $243,500 |
|---|---|
| Option Awards | $1,223,514 |
| Salary | $487,000 |
| Stock Awards | $1,558,367 |
| Other | $28,211 |
| Total | $3,540,592 |
O'Brien received $1.6M in stock awards, accounting for 44% of the total pay in 2016.
O'Brien also received $243.5K in bonus, $1.2M in option awards, $487K in salary and $28.2K in other compensation.
Rankings
In 2016, Christopher F. O'Brien's compensation ranked 2,597th out of 14,075 executives tracked by ExecPay. In other words, O'Brien earned more than 81.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,597 out of 14,075 | 82nd |
Division Manufacturing | 888 out of 5,489 | 84th |
Major group Chemicals And Allied Products | 261 out of 1,895 | 86th |
Industry group Drugs | 188 out of 1,538 | 88th |
Industry Biological Products, Except Diagnostic Substances | 41 out of 279 | 85th |
Source: SEC filing on April 20, 2017.
O'Brien's colleagues
We found five more compensation records of executives who worked with Christopher F. O'Brien at Neurocrine Biosciences in 2016.
2016
Kevin Gorman
Neurocrine Biosciences
Chief Executive Officer
2016
Timothy Coughlin
Neurocrine Biosciences
Chief Financial Officer
2016
Haig Bozigian
Neurocrine Biosciences
Chief Development Officer
2016
Eric Benevich
Neurocrine Biosciences
Chief Commercial Officer
2016
Kyle Gano
Neurocrine Biosciences